See more : 92 Energy Limited (NTELF) Income Statement Analysis – Financial Results
Complete financial analysis of Bone Biologics Corporation (BBLGW) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Bone Biologics Corporation, a leading company in the Medical – Devices industry within the Healthcare sector.
- Transformers and Rectifiers (India) Limited (TRIL.NS) Income Statement Analysis – Financial Results
- Inter & Co, Inc. (INTR) Income Statement Analysis – Financial Results
- GS Chain plc (GSC.L) Income Statement Analysis – Financial Results
- Elegant Floriculture & Agrotech (India) Limited (ELEFLOR.BO) Income Statement Analysis – Financial Results
- CML Microsystems plc (CML.L) Income Statement Analysis – Financial Results
Bone Biologics Corporation (BBLGW)
About Bone Biologics Corporation
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. Its NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. The company is developing NELL-1/DBX Fusion Device for spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L4-S1. Its platform technology has application in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. The company has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 50.00 | 96.00 | 96.00 | 700.00 | 4.45K | 877.78K | 0.00 | 0.00 | 3.00K | 3.00K | 3.00K | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | -50.00 | -96.00 | -96.00 | -700.00 | -4.45K | -877.78K | 0.00 | 0.00 | -3.00K | -3.00K | -3.00K | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 6.91M | 1.58M | 82.04K | 340.67K | 1.10M | 104.49K | -1.19M | 11.60M | 3.67M | 623.52K | 188.24K | 255.58 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 2.52M | 2.09M | 1.02M | 484.34K | 1.35M | 2.69M | 3.82M | 6.25M | 8.33M | 1.51M | 483.75K | 180.09 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 2.52M | 2.09M | 1.02M | 484.34K | 1.35M | 2.69M | 3.82M | 6.25M | 8.33M | 1.51M | 483.75K | 180.09 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 104.49K | 2.63M | 0.00 | 0.00 | -9.62K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -13.34K |
| Operating Expenses | 9.43M | 3.67M | 1.10M | 825.01K | 2.45M | 2.79M | 2.63M | 17.85M | 12.00M | 3.01M | 671.99K | 435.66 | 0.00 | 0.00 | 0.00 | -13.34K |
| Cost & Expenses | 9.43M | 3.67M | 1.10M | 825.01K | 2.45M | 2.79M | 2.63M | 17.85M | 12.00M | 3.01M | 671.99K | 435.66 | 3.00K | 3.00K | 3.00K | -13.34K |
| Interest Income | 1.87K | 731.71 | 805.11 | 998.08 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 805.11K | 998.08K | 975.77K | 1.23M | 4.42M | 3.17M | 1.87M | 1.40M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 9.43M | 3.67M | 1.10M | 50.00 | 50.00 | 96.00 | 96.00 | 700.00 | 4.45K | 280.00 | 671.99K | 435.66 | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA | 479.57K | 0.00 | 0.00 | -825.01K | -2.45M | -2.79M | -2.63M | -20.41M | -11.99M | -3.02M | 0.00 | -5.23K | -4.52K | -3.00K | -3.00K | -13.34K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -9.43M | -3.67M | -1.10M | -825.01K | -2.45M | -2.79M | -2.63M | -17.85M | -12.00M | -3.01M | -671.99K | -435.66 | -3.00K | -3.00K | -3.00K | -13.34K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 479.57K | 2.18M | -507.61K | -998.08K | -975.77K | -1.64M | -4.42M | -614.69K | -1.87M | -1.41M | -409.42K | -4.80K | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax | -8.95M | -1.48M | -1.61M | -1.82M | -3.42M | -4.43M | -7.05M | -21.03M | -13.87M | -4.42M | -1.08M | -714.77 | 0.00 | 0.00 | 0.00 | -13.34K |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | -2.18M | 1.60K | 1.60K | 1.60K | 1.73K | 1.60K | 2.24K | 8.84K | 1.60K | 800.00 | 0.80 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -8.95M | 695.93K | -1.61M | -1.82M | -3.42M | -4.43M | -7.05M | -21.03M | -13.88M | -4.42M | -1.08M | -715.57 | 0.00 | 0.00 | 0.00 | -13.34K |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -34.01 | -31.15 | -37.35 | -35.68 | -66.97 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -49.11 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | -34.01 | -31.15 | -37.35 | -35.68 | -66.97 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -49.11 | 0.00 | 0.00 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 263.14K | 47.00K | 43.00K | 51.00K | 51.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 14.00 | 5.00M | 5.00M | 5.00M | 5.00M |
| Weighted Avg Shares Out (Dil) | 263.14K | 47.66K | 43.13K | 51.14K | 51.14K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 14.57 | 5.00M | 5.00M | 5.00M | 5.00M |
Source: https://incomestatements.info
Category: Stock Reports